Alligator Bioscience AB (publ) (ATORX.ST)
SEK 0.27
(-3.79%)
SEK 0.27
(-3.79%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -189.28 Million | -172.6 Million | -127.03 Million | -141.35 Million | -178.96 Million | -104.11 Million |
| Net Income | -248.58 Million | -192.78 Million | -141.56 Million | -144.29 Million | -214.51 Million | -153.08 Million |
| Depreciation & Amortization | 10.48 Million | 11.76 Million | 11.14 Million | 11.52 Million | 11.54 Million | 5.9 Million |
| Deferred income taxes | 26.68 Million | - | -236 Thousand | - | 1.33 Million | - |
| Stock-based compensation | 74 Thousand | 99 Thousand | 4000.00 | 42 Thousand | 301 Thousand | 397 Thousand |
| Change in working capital | 47.73 Million | 8.98 Million | 3.55 Million | -8.48 Million | 20.24 Million | 40.74 Million |
| Other non-cash items | 1 Million | -665 Thousand | 65 Thousand | -129 Thousand | 2.12 Million | 2.31 Million |
| Investing Cash Flow | -2.45 Million | -440 Thousand | -45 Thousand | 156.88 Million | 17.81 Million | -7.65 Million |
| Investments in PPE | -2.45 Million | -440 Thousand | -45 Thousand | -102 Thousand | -2.18 Million | -7.66 Million |
| Acquisitions | - | - | - | - | - | 10 Thousand |
| Investment purchases | -50 Million | - | - | - | - | - |
| Sales/Maturities of investments | 50 Million | - | - | 156.98 Million | 20 Million | - |
| Other Investing Activities | -2.45 Million | - | -45 Thousand | 53.72 Million | 169.88 Million | 10 Thousand |
| Financing Cash Flow | 161.56 Million | -7.82 Million | 301.79 Million | -6.14 Million | -6.29 Million | 1000.00 |
| Debt repayment | -9.75 Million | -7.91 Million | -301 Thousand | -354 Thousand | -7.07 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -380 Thousand | - | - | - | - |
| Common Stock Issuance | 171.31 Million | 806 Thousand | 342.66 Million | - | - | - |
| Other Financing Activities | -9.75 Million | 7.56 Million | -40.56 Million | -5.79 Million | 779 Thousand | - |
| Accounts receivables | 13.26 Million | -5.85 Million | -13.58 Million | 2.11 Million | 25.29 Million | 25.97 Million |
| Accounts payables | 34.46 Million | 14.84 Million | 17.14 Million | -10.6 Million | -5.04 Million | 14.76 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 34.46 Million | 14.84 Million | 17.14 Million | -10.6 Million | -5.04 Million | 14.76 Million |
| Cash at beginning of period | 97.3 Million | 278.14 Million | 103.34 Million | 93.89 Million | 362.87 Million | 472.91 Million |
| Cash at end of period | 66.11 Million | 97.3 Million | 278.14 Million | 103.34 Million | 196.87 Million | 362.87 Million |
| Capital Expenditure | -2.45 Million | -440 Thousand | -45 Thousand | -102 Thousand | -2.18 Million | -7.66 Million |
| Effect of forex changes on cash | -1 Million | 32 Thousand | 60 Thousand | 145 Thousand | 1.43 Million | 1.72 Million |
| Net cash flow / Change in cash | -31.18 Million | -180.84 Million | 174.8 Million | 9.45 Million | -166 Million | -110.04 Million |
| Free Cash Flow | -191.74 Million | -173.04 Million | -127.07 Million | -141.45 Million | -181.14 Million | -111.78 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -62.03 Million | -49.21 Million | -62.75 Million | -69.83 Million | -248.58 Million | -52.72 Million |
| Depreciation & Amortization | 2.09 Million | 2.28 Million | 2.52 Million | 2.67 Million | 10.48 Million | 2.68 Million |
| Deferred income taxes | - | - | - | - | 26.68 Million | -8000.00 |
| Stock-based compensation | - | 21 Thousand | 17 Thousand | 22 Thousand | 74 Thousand | 8000.00 |
| Change in working capital | 7.54 Million | 8.74 Million | -22.5 Million | 11.92 Million | 47.73 Million | 3.1 Million |
| Other non-cash items | -5.31 Million | -4.18 Million | 27.49 Million | 735 Thousand | 1 Million | 365 Thousand |
| Investing Cash Flow | - | - | - | -29 Thousand | -2.45 Million | -39 Thousand |
| Investments in PPE | - | - | - | - | -2.45 Million | -39 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -50 Million | -50 Million | - |
| Sales/Maturities of investments | - | - | - | 50 Million | 50 Million | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 28.16 Million | 75.62 Million | 56.63 Million | 47.44 Million | 161.56 Million | -39.92 Million |
| Debt repayment | -30 Million | -8.79 Million | -58.79 Million | -2.35 Million | -9.75 Million | -2.44 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | 8000.00 | -8000.00 | - | - | - |
| Common Stock Issuance | - | 90.55 Million | -8000.00 | -234 Thousand | 171.31 Million | 13.75 Million |
| Other Financing Activities | -1.83 Million | -4 Million | 1000.00 | 47.67 Million | -9.75 Million | -51.22 Million |
| Accounts receivables | -2.79 Million | 2.33 Million | 2.12 Million | 5.17 Million | 13.26 Million | 572 Thousand |
| Accounts payables | 10.34 Million | 6.41 Million | -24.63 Million | 6.74 Million | 34.46 Million | 2.53 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 10.34 Million | 6.41 Million | -24.63 Million | 6.74 Million | 34.46 Million | 2.53 Million |
| Cash at beginning of period | 77.5 Million | 40.02 Million | 66.11 Million | 73.91 Million | 97.3 Million | 160.55 Million |
| Cash at end of period | 47.79 Million | 77.5 Million | 40.02 Million | 66.11 Million | 66.11 Million | 73.91 Million |
| Capital Expenditure | - | - | - | - | -2.45 Million | -39 Thousand |
| Effect of forex changes on cash | -168 Thousand | 53 Thousand | 64 Thousand | -716 Thousand | -1 Million | -137 Thousand |
| Net cash flow / Change in cash | -29.71 Million | 37.48 Million | -26.09 Million | -7.8 Million | -31.18 Million | -86.63 Million |
| Free Cash Flow | -57.71 Million | -38.19 Million | -82.79 Million | -54.5 Million | -191.74 Million | -46.6 Million |
PVBC
2318
JUTOY
6629
RNO
1024